Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Clene Inc. (CLNN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Clene Inc. (CLNN), most recent 12 months reported: revenue $197K, net loss $39.52M, free cash flow -$18.59M. Latest balance sheet on file: liquid cash $9.67M, total debt $18.31M, net cash -$8.64M. From SEC filings. Others in Pharmaceutical Preparations: PROVECTUS BIOPHARMACEUTICALS, INC. · CervoMed Inc. · Allarity Therapeutics, Inc. · REGEN BIOPHARMA, INC. · LEXARIA BIOSCIENCE CORP. · Lisata Therapeutics, Inc. · Serina Therapeutics, Inc. · VYOME HOLDINGS, INC.

Stock screener

Watchlist